Travera, LLC
Software platform that analyzes FDA-approved drugs against individual cancer patient genomics and clinical data to recommend personalized treatment options
New patent ·
- Sector
- Digital health
- Headquarters
- MEDFORD, MA
- Founded
- 2017
- Latest Form D
- $4M, Jul 2021
- Total capital
- $11.6M
- Federal grants
- $2.2M
- 4 awards · 2019–2020
- Rank in peer group#18 of 21
- Private capital raised
- $9.4M
- 3 Form D · last Jul 2021
- 63 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 17 pending · first 2022
- Rank in peer group#1 of 21
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$4M
- Federal grantNSF · Phase II · SBIR Phase II: Developing suspended microchannel resonators as a platform for personalized medicine in cancer$1.5M
- Federal grantHealth and Human S · Phase I · A functional assay for ex vivo determination of drug susceptibility for multiple myeloma patients$224K
- Federal grantHealth and Human S · Phase I · A functional assay for ex vivo determination of drug susceptibility for multiple myeloma patients$224K
- Federal grantNSF · Phase I · SBIR Phase I: Developing serial suspended microchannel resonators as a platform for personalized medicine in cancer$225K
- Private capital raisedForm D · SEC · 2nd filing$4.6M
- Private capital raisedForm D · SEC · 1st filing$850K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 21 peers
Line = medianDigital health · Platform
- Federal grantsBelow median
- Granted patents#1 · top 5%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Clifford A. ReidExecutive Officer, DirectorNamed in SEC Form D filings
- David A. MarguliesDirectorNamed in SEC Form D filings
- Laurence Robert JohnsonDirectorNamed in SEC Form D filings
- L. Robert JohnsonDirectorNamed in SEC Form D filings
- L. Robert A. JohnsonDirectorNamed in SEC Form D filings
- Patrick A. ZhangDirectorNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 22- New patentAssessing Immune System Function And StatusUSPTOUS 12,754,123
- PendingAssessing Immune System Function And StatusUSPTOApplication 19388956
- PendingIdentifying Cancer TherapiesUSPTOApplication 19265873
Show all 22 patent records
- Assessing Immune System Function And StatusOct 6, 2026 · US 12,754,123Granted
- Assessing Immune System Function And StatusMar 12, 2026 · Application 19388956Pending
- Identifying Cancer TherapiesJan 1, 2026 · Application 19265873Pending
- Cellular Measurement, Calibration, And ClassificationDec 25, 2025 · Application 19255047Pending
- Identifying Cancer TherapiesJul 15, 2025 · US 12,362,038Granted
- Cellular Measurement, Calibration, And ClassificationJul 1, 2025 · US 12,345,622Granted
- Treatment Response Assessment Using Normalized Single Cell MeasurementsJan 16, 2025 · Application 18899213Pending
- Treatment Response Assessment Using Normalized Single Cell MeasurementsOct 1, 2024 · US 12,105,081Granted
- Cellular Measurement, Calibration, And ClassificationSep 12, 2024 · Application 18667795Pending
- Assessing Immune System Function And StatusJun 1, 2023 · Application 17977341Pending
- Cellular Measurement Calibration And ClassificationMar 9, 2023 · Application 17901190Pending
- Cellular Measurement, Calibration, And ClassificationDec 20, 2022 · US 11,530,974Granted
- Calibration Of A Functional Biomarker InstrumentAug 11, 2022 · Application 17732769Pending
- Machine Learning In Functional Cancer AssaysJul 16, 2020 · Application 16739814Pending
- Multimodal Measurements Of Cellular MassApplication 63274255Pending
- Cellular Assessment Using Mass DistributionApplication 63257906Pending
- Assessing Immune System Function And StatusApplication PCTUS2022048389Pending
- Treatment Response Assessment Using Normalized Single Cell MeasurementsApplication 63278420Pending
- Cellular Measurement Calibration And ClassificationApplication PCTUS2022042330Pending
- Cellular Measurement Calibration And ClassificationApplication PCTUS2022048390Pending
- Treatment Response Assessment Using Normalized Single Cell MeasurementsApplication PCTUS2022047231Pending
- Assessing Immune System Function And StatusApplication 63274226Pending
Related companies, and why
- Longr Holdings Inc.Similar federal contract value in Digital health · null in contracts
- DABBLE HEALTH, INC.Similar federal contract value in Digital health · null in contracts
- RADECT INC.Similar federal contract value in Digital health · null in contracts
- 23ANDME, INC.Similar federal contract value in Digital health · null in contracts
- DECODE HEALTH, INC.Similar federal contract value in Digital health · null in contracts
- KINIMA, INC.Similar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .